Geode Capital Management LLC Raises Position in Teleflex Incorporated (NYSE:TFX)

Geode Capital Management LLC raised its position in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 0.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,138,867 shares of the medical technology company's stock after acquiring an additional 8,307 shares during the quarter. Geode Capital Management LLC owned about 2.45% of Teleflex worth $202,161,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the business. HighTower Advisors LLC increased its stake in shares of Teleflex by 1.7% in the 3rd quarter. HighTower Advisors LLC now owns 3,998 shares of the medical technology company's stock valued at $986,000 after acquiring an additional 66 shares in the last quarter. Hengehold Capital Management LLC grew its holdings in Teleflex by 7.3% in the fourth quarter. Hengehold Capital Management LLC now owns 1,289 shares of the medical technology company's stock worth $229,000 after purchasing an additional 88 shares during the period. Exchange Traded Concepts LLC increased its stake in Teleflex by 38.2% in the fourth quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company's stock valued at $61,000 after purchasing an additional 94 shares in the last quarter. Isthmus Partners LLC raised its holdings in shares of Teleflex by 7.3% during the fourth quarter. Isthmus Partners LLC now owns 1,535 shares of the medical technology company's stock valued at $273,000 after purchasing an additional 105 shares during the period. Finally, Sumitomo Mitsui DS Asset Management Company Ltd boosted its position in shares of Teleflex by 2.4% during the 4th quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 4,991 shares of the medical technology company's stock worth $888,000 after purchasing an additional 118 shares in the last quarter. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Teleflex Stock Up 0.6 %

Shares of TFX traded up $0.74 during trading hours on Friday, reaching $129.81. 642,249 shares of the stock traded hands, compared to its average volume of 614,950. Teleflex Incorporated has a 52 week low of $124.66 and a 52 week high of $249.91. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The stock has a fifty day simple moving average of $148.00 and a 200 day simple moving average of $181.53. The company has a market cap of $6.02 billion, a price-to-earnings ratio of 25.81, a PEG ratio of 1.73 and a beta of 1.19.

Teleflex (NYSE:TFX - Get Free Report) last announced its earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, topping analysts' consensus estimates of $3.86 by $0.03. The firm had revenue of $795.40 million for the quarter, compared to the consensus estimate of $813.24 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. On average, equities analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Friday, March 7th were given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 1.05%. The ex-dividend date of this dividend was Friday, March 7th. Teleflex's dividend payout ratio is presently 95.77%.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on TFX. Morgan Stanley dropped their price target on Teleflex from $275.00 to $191.00 and set an "overweight" rating on the stock in a research note on Wednesday, March 5th. Needham & Company LLC reaffirmed a "hold" rating on shares of Teleflex in a research report on Wednesday, March 12th. StockNews.com downgraded shares of Teleflex from a "buy" rating to a "hold" rating in a research report on Friday, February 28th. Royal Bank of Canada downgraded shares of Teleflex from an "outperform" rating to a "sector perform" rating and lowered their price objective for the stock from $220.00 to $155.00 in a report on Friday, February 28th. Finally, Wells Fargo & Company dropped their price objective on shares of Teleflex from $214.00 to $146.00 and set an "equal weight" rating on the stock in a research note on Friday, February 28th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, Teleflex currently has an average rating of "Hold" and an average target price of $181.50.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.